{{Rsnum
|rsid=3135730
|Gene=FGFR2
|Chromosome=10
|position=123325794
|Orientation=minus
|GMAF=0.1804
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 83.9 | 14.3 | 1.8
| HCB | 81.8 | 17.5 | 0.7
| JPT | 88.5 | 11.5 | 0.0
| YRI | 22.4 | 57.8 | 19.7
| ASW | 33.3 | 49.1 | 17.5
| CHB | 81.8 | 17.5 | 0.7
| CHD | 85.3 | 14.7 | 0.0
| GIH | 98.0 | 1.0 | 1.0
| LWK | 37.3 | 50.9 | 11.8
| MEX | 63.8 | 32.8 | 3.4
| MKK | 48.1 | 46.2 | 5.8
| TSI | 85.3 | 12.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21382839
|Title=Relation of FGFR2 Genetic Polymorphisms to the Association Between Oral Contraceptive Use and the Risk of Breast Cancer in Chinese Women
|OA=1
}}

{{PMID Auto
|PMID=18285324
|Title=Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}